A subset analysis was performed for those patients having advanced liver fibrosis/ cirrhosis at baseline( Ishak score :4-6), evaluating the impact of 48 weeks of ETV or LMV treatment.

• 对基线时表现为中重度肝纤维化/硬化患者(Ishak评分:4-6)进行亚组分析,评估ETV或LMV治疗48周的疗效。